208 related articles for article (PubMed ID: 11060487)
1. Anti-tetanus toxoid antibody production and protection against lethal doses of tetanus toxin in hu-PBL-SCID mice.
Naito S; Okada Y; Takahashi M; Kato H; Taneichi M; Ami Y; Suzaki Y; Oka T; Okuma K; Morokuma K; Onodera H; Inoue M; Takahashi Y; Yamazaki S; Kimura H; Komuro K; Uchida T
Int Arch Allergy Immunol; 2000 Oct; 123(2):149-54. PubMed ID: 11060487
[TBL] [Abstract][Full Text] [Related]
2. Induction of protection against tetanus toxin in mice by tetanus toxoid-liposome conjugate.
Naito S; Horino A; Komiya T; Fukuda T; Takahashi M; Ami Y; Suzaki Y; Oka T; Okuma K; Morokuma M; Nakano Y; Mori M; Nishinohara S; Komuro K; Uchida T
Int Arch Allergy Immunol; 1998 Jul; 116(3):215-9. PubMed ID: 9693269
[TBL] [Abstract][Full Text] [Related]
3. Reduction of human anti-tetanus toxoid antibody in hu-PBL-SCID mice by immunodominant peptides of tetanus toxoid.
Jackson DJ; Elson CJ; Kumpel BM
Clin Exp Immunol; 2004 Aug; 137(2):245-52. PubMed ID: 15270840
[TBL] [Abstract][Full Text] [Related]
4. The hu-PBL-SCID mouse model. Long-term human serologic evolution associated with the xenogeneic transfer of human peripheral blood leukocytes into SCID mice.
Duchosal MA; Eming SA; McConahey PJ; Dixon FJ
Cell Immunol; 1992 Feb; 139(2):468-77. PubMed ID: 1733515
[TBL] [Abstract][Full Text] [Related]
5. Optimisation of human anti-tetanus toxoid antibody responses and location of human cells in SCID mice transplanted with human peripheral blood leucocytes.
Jackson DJ; Kumpel BM
Hum Antibodies; 1997; 8(4):181-8. PubMed ID: 9395920
[TBL] [Abstract][Full Text] [Related]
6. Human antibody response to a pneumococcal vaccine in SCID-PBL-hu mice and simultaneously vaccinated human cell donors.
Aaberge IS; Steinsvik TE; Groeng EC; Leikvold RB; Løvik M
Clin Exp Immunol; 1996 Jul; 105(1):12-7. PubMed ID: 8697618
[TBL] [Abstract][Full Text] [Related]
7. SCID-Hu mice immunized with a pneumococcal vaccine produce specific human antibodies and show increased resistance to infection.
Aaberge IS; Michaelsen TE; Rolstad AK; Groeng EC; Solberg P; Løvik M
Infect Immun; 1992 Oct; 60(10):4146-53. PubMed ID: 1398925
[TBL] [Abstract][Full Text] [Related]
8. Characterization of hu-PBL-SCID mice with high human immunoglobulin serum levels and graft-versus-host disease.
Duchosal MA; Eming SA; McConahey PJ; Dixon FJ
Am J Pathol; 1992 Nov; 141(5):1097-113. PubMed ID: 1332484
[TBL] [Abstract][Full Text] [Related]
9. Antigen-specific T cell responses in human peripheral blood leucocyte (hu-PBL)-mouse chimera conditioned with radiation and an antibody directed against the mouse IL-2 receptor beta-chain.
Cao T; Leroux-Roels G
Clin Exp Immunol; 2000 Oct; 122(1):117-23. PubMed ID: 11012627
[TBL] [Abstract][Full Text] [Related]
10. Specific antibody production to a recall or a neoantigen by SCID mice reconstituted with human peripheral blood lymphocytes.
Nonoyama S; Smith FO; Ochs HD
J Immunol; 1993 Oct; 151(7):3894-901. PubMed ID: 8376809
[TBL] [Abstract][Full Text] [Related]
11. A promising model of primary human immunization in human-scid mouse.
Bombil F; Kints JP; Scheiff JM; Bazin H; Latinne D
Immunobiology; 1996 Aug; 195(3):360-75. PubMed ID: 8877409
[TBL] [Abstract][Full Text] [Related]
12. The in vivo production of specific human antibodies by vaccination of human-PBL-SCID mice.
Walker W; Gallagher G
Immunology; 1994 Oct; 83(2):163-70. PubMed ID: 7530687
[TBL] [Abstract][Full Text] [Related]
13. The ocular conjunctiva as a mucosal immunization route: a profile of the immune response to the model antigen tetanus toxoid.
Barisani-Asenbauer T; Inic-Kanada A; Belij S; Marinkovic E; Stojicevic I; Montanaro J; Stein E; Bintner N; Stojanovic M
PLoS One; 2013; 8(4):e60682. PubMed ID: 23637758
[TBL] [Abstract][Full Text] [Related]
14. The use of the hu-PBL-SCID mouse model to study lymphocyte homing and responsiveness to recall antigens.
Lue C; Kiyono H; Fujihashi K; McGhee JR; Mestecky J
Reg Immunol; 1992; 4(2):86-90. PubMed ID: 1503891
[TBL] [Abstract][Full Text] [Related]
15. Co-expression of tetanus toxin fragment C in Escherichia coli with thioredoxin and its evaluation as an effective subunit vaccine candidate.
Yu YZ; Gong ZW; Ma Y; Zhang SM; Zhu HQ; Wang WB; Du Y; Wang S; Yu WY; Sun ZW
Vaccine; 2011 Aug; 29(35):5978-85. PubMed ID: 21718736
[TBL] [Abstract][Full Text] [Related]
16. Evidence for restricted diversity of antigen-specific human antibodies in immunized hu-PBL-SCID mice.
Bazin R; Chevrier MC; Delage R; Lemieux R
Hum Antibodies Hybridomas; 1996; 7(3):129-34. PubMed ID: 9057061
[TBL] [Abstract][Full Text] [Related]
17. Epitope repertoire of human CD4+ lines propagated with tetanus toxoid or with synthetic tetanus toxin sequences.
Raju R; Diethelm-Okita B; Okita D; Conti-Fine BM
J Autoimmun; 1996 Feb; 9(1):79-88. PubMed ID: 8845057
[TBL] [Abstract][Full Text] [Related]
18. Human peripheral blood lymphocytes transplanted into SCID mice constitute an in vivo culture system exhibiting several parameters found in a normal humoral immune response and are a source of immunocytes for the production of human monoclonal antibodies.
Carlsson R; Mårtensson C; Kalliomäki S; Ohlin M; Borrebaeck CA
J Immunol; 1992 Feb; 148(4):1065-71. PubMed ID: 1737926
[TBL] [Abstract][Full Text] [Related]
19. Role of interleukin-4 in human immunoglobulin E formation in hu-PBL-SCID mice.
Spiegelberg HL; Beck L; Kocher HP; Fanslow WC; Lucas AH
J Clin Invest; 1994 Feb; 93(2):711-7. PubMed ID: 8113405
[TBL] [Abstract][Full Text] [Related]
20. Tetanus vaccination with a dissolving microneedle patch confers protective immune responses in pregnancy.
Esser ES; Romanyuk A; Vassilieva EV; Jacob J; Prausnitz MR; Compans RW; Skountzou I
J Control Release; 2016 Aug; 236():47-56. PubMed ID: 27327766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]